Position in RGNX
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$2,722,326
-$1,606,441 QoQ
Shares Held
324,860
+8.1% QoQ
Ownership
0.628%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 93.21399987687003.ToString("F0")%
Shared 0.ToString("F0")%
None 6.786000123129964.ToString("F0")%
Common Shares in RGNX Over Time
Shares Held
Position Value (USD)
Derivatives in RGNX
reported options exposure · as of Jun 30, 2022CallValue
$741,000
CallShares
30,000
PutValue
$741,000
PutShares
30,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026BANK OF AMERICA CORP /DE/ holds $8,554,846,017 across 346 Biotechnology names. RGNX ranks #161 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,878,183 | $1,285,223,834 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,189,584 | $919,120,177 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
966,912 | $319,922,169 | |
| 4 | ARGX |
Argenx SE
|
400,117 | $292,185,437 | |
| 5 | INSM |
INSMED Inc
|
1,502,281 | $245,652,986 | |
| 6 | CYTK |
Cytokinetics Inc
|
3,125,436 | $205,997,485 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
1,014,800 | $191,847,936 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
2,913,109 | $188,274,232 |
All Filings in RGNX
Export CSV
29 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,722,326 | 324,860 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $4,328,767 | 300,609 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $4,007,701 | 415,306 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $4,700,214 | 572,499 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $4,661,390 | 651,943 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $2,173,704 | 281,204 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $4,680,469 | 446,184 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $2,298,896 | 196,487 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $3,428,066 | 162,699 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $2,382,825 | 132,748 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $2,610,800 | 158,615 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $2,687,931 | 134,464 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $3,748,905 | 198,250 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $3,765,242 | 166,016 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $3,554,807 | 134,499 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $995,087 | 40,287 | Shares | Defined | 2022-08-12 | |
| 2022-06-30 | $741,000 | 30,000 | Put | Defined | 2022-08-12 | |
| 2022-06-30 | $741,000 | 30,000 | Call | Defined | 2022-08-12 | |
| 2022-03-31 | $995,700 | 30,000 | Call | Defined | 2022-05-16 | |
| 2022-03-31 | $5,847,876 | 176,194 | Shares | Defined | 2022-05-16 | |
| 2022-03-31 | $995,700 | 30,000 | Put | Defined | 2022-05-16 | |
| 2021-12-31 | $4,020,594 | 122,954 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $1,999,917 | 47,708 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $2,197,004 | 56,551 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | $5,196,998 | 152,360 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $3,588,745 | 79,117 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $2,016,416 | 73,271 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $4,525,005 | 122,862 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $733,146 | 22,642 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||